MTO1 (C-Term) Peptide
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits MTO1
- MTO1
- Protein Region
- C-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- HFSRPQTIGA ASRIPGVTPA AIINLLRFVK TTQRRQSAMN ESSKTDQYLC
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MTO1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- MTO1
- Synonymes
- 2310039H01Rik Peptide, 5730419A02Rik Peptide, COXPD10 Peptide, mitochondrial tRNA translation optimization 1 Peptide, Mto1 Peptide, MTO1 Peptide
- Sujet
-
This gene encodes a mitochondrial protein thought to be involved in mitochondrial tRNA modification. The encoded protein may also play a role in the expression of the non-syndromic and aminoglycoside-induced deafness phenotypes associated with a specific mutation in the mitochondrial 12S rRNA gene. Multiple transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: CGI-02, COXPD10
Protein Size: 595 - ID gène
- 25821
- NCBI Accession
- NM_001123226, NP_001116698
-
Vous êtes ici:
